Michael Aaron Kelly Neogenomics Inc (NEO) insider trading activity

Michael Aaron Kelly is Director of NEOGENOMICS INC. Currently has a direct ownership of 44,009 shares of NEO, which is worth approximately $315,544. The most recent transaction as insider was on Jun 01, 2025, when has been sold 12,254 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 44K

38.59% 3M change

115.53% 12M change

Total Value Held $315,544

Michael Aaron Kelly Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 01 2025	BUY Exercise of conversion of derivative security	-	12,254 Added 21.78%	44,009 Common Stock
Aug 10 2024	BUY Exercise of conversion of derivative security	-	11,336 Added 26.31%	31,755 Common Stock
Jun 10 2022	BUY Grant, award, or other acquisition	-	15,556 Added 43.24%	20,419 Common Stock
Jun 02 2021	BUY Grant, award, or other acquisition	-	3,081 Added 38.78%	4,863 Common Stock

Also insider at

FOLD

AMICUS THERAPEUTICS, INC. Healthcare

BOOM

DMC Global Inc. Energy

Director

HOOK

HOOKIPA Pharma Inc. Healthcare

Director

APRE

Aprea Therapeutics, Inc. Healthcare

Director

PRME

Prime Medicine, Inc.

Director

MAK